With an aim to make Madhya Pradesh anaemia-free, the state government has decided to launch a scheme-'Lalima Abhiyan'- that will be effective from November 1. Under the campaign, free iron folic acid tablets will be provided in aaganwadis', academic institutions and hospitals.
Madhya Pradesh Chief Minister Shivraj Singh Chouhan has also urged the state's Health Minister, Jagat Prasad Nadda, to distribute ferrous escorbate tablets instead of ferrous sulphate tablets.
The Center has assured full cooperation to the state government in the matter.
The Minister for Women and Child Development, Archana Chitnis, said anaemia is a common health problem among women, teenage girls and children.
Acoording to National Family Health Survey data, 52.5 percent of women, aged between 15 to 49 years, are suffering from anaemia.
Natural, modern and traditional measures will be publicised during the campaign that will involve the Public Health Engineering, Ayush and School Education Department as well.
Minister of State for Women and Child Development Lalita Yadav has appealed to public representatives, non-governmental organisations and government officers and employees to cooperate for the success of the campaign, he added.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!